https://www.giantrawsource.com/raw-steroid-powder/raws-powder-exemestane-aromasin.htmlWomen in the exemestane group also had a 19 percent lower risk of a breast cancer recurrence. In addition, the exemestane group had a 16 percent lower risk of a distant recurrence (metastatic disease). The benefits of exemestane were maintained over time, even after treatment had stopped.
